Inventor · disambiguated record
Dharam Paul
Also filed as: PAUL DHARAM
19 granted patents·7 pending applications·22 citations·filing 2007–2022
90Inventor score
Files withBIONOMICS LTD11FLYNN BERNARD LUKE5MERCK SHARP & DOHME3MERCK SHARP & DOHME LLC3HARVEY ANDREW2
Top patents by PatentIndex Score
26 records- 0177US9023848B2Small-molecules as therapeuticsFLYNN BERNARD LUKE·Filed 2012·Granted May 5, 2015·5 cites·19 claims
- 0276US9758516B2Crystalline form of an anxiolytic compoundBIONOMICS LTD·Filed 2013·Granted Sep 12, 2017·2 cites·35 claims
- 0375US9790173B2Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof-IMERCK SHARP & DOHME·Filed 2017·Granted Oct 17, 2017·2 cites·7 claims
- 0475US9062013B2Positive allosteric modulators of the α7 nicotinic acetylcholine receptor and uses thereofHARVEY ANDREW·Filed 2012·Granted Jun 23, 2015·5 cites·18 claims
- 0574US9745296B2Salts, co-crystals, and polymorphs of an anxiolytic compoundBIONOMICS LTD·Filed 2014·Granted Aug 29, 2017·2 cites·15 claims
- 0673US9133188B2Methods for preparing naphthyridinesPAUL DHARAM·Filed 2012·Granted Sep 15, 2015·4 cites·19 claims
- 0769US8202513B2Aryl potassium channel blockers and uses thereofFLYNN BERNARD LUKE·Filed 2008·Granted Jun 19, 2012·1 cites·21 claims
- 0864US9493451B2Amine derivatives as potassium channel blockersHARVEY ANDREW·Filed 2012·Granted Nov 15, 2016·1 cites·28 claims
- 0957US2024368109A1Allosteric modulators of nicotinic acetylcholine receptorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1055US2025002448A1Allosteric modulators of nicotinic acetylcholine receptorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1154US9914702B2Amine derivatives as potassium channel blockersBIONOMICS LTD·Filed 2016·Granted Mar 13, 2018·0 cites·7 claims
- 1254US2018273476A1Amine derivatives as potassium channel blockersBIONOMICS LTD·Filed 2018·Application pending·0 cites
- 1353US12409140B2Therapeutic formulations and uses thereofBIONOMICS LTD·Filed 2020·Granted Sep 9, 2025·0 cites·15 claims
- 1451US8309545B2Benzofuran potassium channel blockers and uses thereofFLYNN BERNARD LUKE·Filed 2007·Granted Nov 13, 2012·0 cites·9 claims
- 1550US12090146B2Substituted-pyridinyl compounds and uses thereofBIONOMICS LTD·Filed 2019·Granted Sep 17, 2024·0 cites·12 claims
- 1649US8217189B2Chromenone potassium channel blockers and uses thereofFLYNN BERNARD LUKE·Filed 2007·Granted Jul 10, 2012·0 cites·35 claims
- 1747US12331022B2Spiropiperidine allosteric modulators of nicotinic acetylcholine receptorsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 17, 2025·0 cites·5 claims
- 1847US12139473B2Substituted-N-heteroaryl compounds and uses thereofBIONOMICS LTD·Filed 2019·Granted Nov 12, 2024·0 cites·14 claims
- 1947US10266529B2Salts, co-crystals, and polymorphs of an anxiolytic compoundBIONOMICS LTD·Filed 2017·Granted Apr 23, 2019·0 cites·15 claims
- 2047US8466163B2Furo[2,3-d]pyrimidines and related compounds and methods for treating disease states by inhibiting tubulin polymerizationFLYNN BERNARD LUKE·Filed 2007·Granted Jun 18, 2013·0 cites·16 claims
- 2147US2017305905A1Crystalline form of an anxiolytic compoundBIONOMICS LTD·Filed 2017·Application pending·0 cites
- 2247US2015175534A1Alpha-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEROF-IMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 2346US2015299184A1Amine Derivatives as Potassium Channel BlockersBIONOMICS LTD·Filed 2015·Application pending·0 cites
- 2442US8507539B2Potassium channel blockers and uses thereofHARVEY ANDREW JOHN·Filed 2009·Granted Aug 13, 2013·0 cites·22 claims
- 2537US2015246029A1Positive Allosteric Modulators and Uses ThereofBIONOMICS LTD·Filed 2015·Application pending·0 cites
- 2631US9994518B2Alpha-7 nicotinic acetylcholine receptor modulators and uses thereofMERCK SHARP & DOHME·Filed 2015·Granted Jun 12, 2018·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Dharam Paul files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →